Emergent BioSolutions
| Use attributes for filter ! | |
| Stock price | EBS |
|---|---|
| Disclaimer | |
| Headquarters | Rockville |
| Maryland | |
| United States | |
| Revenue | 1.793 billion USD |
| Subsidiaries | PaxVax |
| Cangene | |
| ADAPT Pharma Inc. | |
| Emergent BioSolutions Canada Inc. | |
| Key people | Robert G. Kramer Sr. |
| Fuad El-Hibri | |
| Stock quote | EBS |
| Disclaimer | |
| Ceo | Robert G. Kramer Sr. |
| Number of employees | 2,416 |
| Founders | Fuad El-Hibri |
| Founded | September 5 |
| 1998 | |
| Presidents | Robert G. Kramer Sr. |
| Date of Reg. | |
| Date of Upd. | |
| ID | 942356 |
About Emergent BioSolutions
Emergent BioSolutions Inc. is an American multinational specialty biopharmaceutical company headquartered in Gaithersburg, Maryland. It develops vaccines and antibody therapeutics for infectious diseases and opioid overdoses, and it provides medical devices for biodefense purposes.
